PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9533760-0	1998	Goralatide (AcSDKP), a negative growth regulator, protects the stem cell compartment during chemotherapy, enhancing the myelopoietic response to GM-CSF.	goralatide	0-10	colony stimulating factor 2 (granulocyte-macrophage)	Mus musculus	145-151	
9533760-1	1998	The aim of our study was to investigate the protection afforded to the bone marrow by Goralatide (AcSDKP), an inhibitor of hemopoietic stem cell proliferation, when administered alone or in combination with a growth factor (granulocyte/macrophage colony-stimulating factor [GM-CSF]) during iterative cycles of Ara-C (cytarabine) treatment.	goralatide	86-96	colony stimulating factor 2 (granulocyte-macrophage)	Mus musculus	274-281	
9533760-5	1998	When the cycles of chemotherapy plus Goralatide were followed by GM-CSF, the recovery from leukopenic nadirs was accelerated and the white blood cells and granulocyte levels were markedly increased over those observed in control mice and in mice treated either with Goralatide alone or with GM-CSF alone.	goralatide	37-47	colony stimulating factor 2 (granulocyte-macrophage)	Mus musculus	65-71	
9533760-5	1998	When the cycles of chemotherapy plus Goralatide were followed by GM-CSF, the recovery from leukopenic nadirs was accelerated and the white blood cells and granulocyte levels were markedly increased over those observed in control mice and in mice treated either with Goralatide alone or with GM-CSF alone.	goralatide	37-47	colony stimulating factor 2 (granulocyte-macrophage)	Mus musculus	291-297	
9533760-5	1998	When the cycles of chemotherapy plus Goralatide were followed by GM-CSF, the recovery from leukopenic nadirs was accelerated and the white blood cells and granulocyte levels were markedly increased over those observed in control mice and in mice treated either with Goralatide alone or with GM-CSF alone.	goralatide	266-276	colony stimulating factor 2 (granulocyte-macrophage)	Mus musculus	65-71	
9533760-7	1998	A consistent and significant increase (p < 0.001) in platelet count was also noted in animals given Goralatide in conjunction with Ara-C or Ara-C + GM-CSF.	goralatide	103-113	colony stimulating factor 2 (granulocyte-macrophage)	Mus musculus	151-157